Zdrowie i gospodarka · 16/12/2008

FDA Releases Draft Guidance on Adverse Event Reporting During Influenza Pandemic

The Food and Drug Administration (FDA) has released a draft guidance for industry on how to report adverse events related to medical products and dietary supplements during an influenza pandemic. The guidance advises the industry to prioritize reports related to influenza products and other specific types of reports.